0001104659-21-064573.txt : 20210511 0001104659-21-064573.hdr.sgml : 20210511 20210511164047 ACCESSION NUMBER: 0001104659-21-064573 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210507 FILED AS OF DATE: 20210511 DATE AS OF CHANGE: 20210511 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LLOYD RONALD K. CENTRAL INDEX KEY: 0001644078 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39577 FILM NUMBER: 21911920 MAIL ADDRESS: STREET 1: C/O MALLINCKRODT PHARMACEUTICALS STREET 2: 675 MCDONNELL BLVD. CITY: HAZELWOOD STATE: MO ZIP: 63042 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AZIYO BIOLOGICS, INC. CENTRAL INDEX KEY: 0001708527 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 474790334 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 12510 PROSPERITY DRIVE STREET 2: SUITE 370 CITY: SILVER SPRING STATE: MD ZIP: 20904 BUSINESS PHONE: 240-247-1143 MAIL ADDRESS: STREET 1: 12510 PROSPERITY DRIVE STREET 2: SUITE 370 CITY: SILVER SPRING STATE: MD ZIP: 20904 4 1 tm2115948-1_4seq1.xml OWNERSHIP DOCUMENT X0306 4 2021-05-07 0 0001708527 AZIYO BIOLOGICS, INC. AZYO 0001644078 LLOYD RONALD K. C/O AZIYO BIOLOGICS, INC., 12510 PROSPERITY DRIVE, SUITE 370 SILVER SPRING MD 20904 1 1 0 0 PRESIDENT AND CEO Class A Common Stock 2021-05-07 4 P 0 7198 11.65 A 21784 D Class A Common Stock 2021-05-07 4 P 0 1367 12.28 A 23151 D The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $11.20 to $12.18. The reporting person undertakes to provide Aziyo Biologics, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $12.25 to $12.39. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. /s/ Ronald Lloyd 2021-05-11